Study of Nasonex for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old

Trial Profile

Study of Nasonex for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Apr 2017

At a glance

  • Drugs Mometasone (Primary)
  • Indications Nasal polyps
  • Focus Adverse reactions; Registrational
  • Sponsors Merck & Co
  • Most Recent Events

    • 15 Apr 2014 New source identified and integrated (ClinicalTrials.gov: NCT00378378)
    • 08 Nov 2013 New trial record
    • 27 Jul 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top